DYN logo

Dyne Therapeutics, Inc. (DYN) Accounts Payable

Annual Accounts Payable:

$6.56M-$16.37M(-71.39%)
December 31, 2024

Summary

  • As of today, DYN annual accounts payable is $6.56 million, with the most recent change of -$16.37 million (-71.39%) on December 31, 2024.
  • During the last 3 years, DYN annual accounts payable has risen by +$2.53 million (+62.79%).
  • DYN annual accounts payable is now -71.39% below its all-time high of $22.94 million, reached on December 31, 2023.

Performance

DYN Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Quarterly Accounts Payable:

$12.06M-$1.96M(-13.95%)
September 30, 2025

Summary

  • As of today, DYN quarterly accounts payable is $12.06 million, with the most recent change of -$1.96 million (-13.95%) on September 30, 2025.
  • Over the past year, DYN quarterly accounts payable has increased by +$5.90 million (+95.89%).
  • DYN quarterly accounts payable is now -47.41% below its all-time high of $22.94 million, reached on December 31, 2023.

Performance

DYN Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

DYN Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-71.4%+95.9%
3Y3 Years+62.8%+1212.4%
5Y5 Years+422.4%+710.5%

DYN Accounts Payable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-71.4%+62.8%-47.4%+1212.4%
5Y5-Year-71.4%+422.4%-47.4%+1212.4%
All-TimeAll-Time-71.4%+1166.8%-47.4%+1212.4%

DYN Accounts Payable History

DateAnnualQuarterly
Sep 2025
-
$12.06M(-13.9%)
Jun 2025
-
$14.02M(+99.7%)
Mar 2025
-
$7.02M(+7.0%)
Dec 2024
$6.56M(-71.4%)
$6.56M(+6.6%)
Sep 2024
-
$6.16M(+225.9%)
Jun 2024
-
$1.89M(-73.8%)
Mar 2024
-
$7.21M(-68.5%)
Dec 2023
$22.94M(+336.1%)
$22.94M(+545.5%)
Sep 2023
-
$3.55M(+30.4%)
Jun 2023
-
$2.72M(-68.9%)
Mar 2023
-
$8.77M(+66.8%)
Dec 2022
$5.26M
$5.26M(+472.3%)
DateAnnualQuarterly
Sep 2022
-
$919.00K(-86.8%)
Jun 2022
-
$6.97M(+34.4%)
Mar 2022
-
$5.19M(+28.7%)
Dec 2021
$4.03M(+17.2%)
$4.03M(-43.1%)
Sep 2021
-
$7.09M(+25.5%)
Jun 2021
-
$5.65M(-1.9%)
Mar 2021
-
$5.76M(+67.4%)
Dec 2020
$3.44M(+173.9%)
$3.44M(+131.2%)
Sep 2020
-
$1.49M(-32.1%)
Jun 2020
-
$2.19M(+74.5%)
Dec 2019
$1.26M(+142.5%)
$1.26M
Dec 2018
$518.00K
-

FAQ

  • What is Dyne Therapeutics, Inc. annual accounts payable?
  • What is the all-time high annual accounts payable for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. annual accounts payable year-on-year change?
  • What is Dyne Therapeutics, Inc. quarterly accounts payable?
  • What is the all-time high quarterly accounts payable for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. quarterly accounts payable year-on-year change?

What is Dyne Therapeutics, Inc. annual accounts payable?

The current annual accounts payable of DYN is $6.56M

What is the all-time high annual accounts payable for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high annual accounts payable is $22.94M

What is Dyne Therapeutics, Inc. annual accounts payable year-on-year change?

Over the past year, DYN annual accounts payable has changed by -$16.37M (-71.39%)

What is Dyne Therapeutics, Inc. quarterly accounts payable?

The current quarterly accounts payable of DYN is $12.06M

What is the all-time high quarterly accounts payable for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high quarterly accounts payable is $22.94M

What is Dyne Therapeutics, Inc. quarterly accounts payable year-on-year change?

Over the past year, DYN quarterly accounts payable has changed by +$5.90M (+95.89%)
On this page